Clinicians Believe Link Between Breast Pain, Cancer Is Weak
Although most believe that the correlation between breast pain and breast cancer is weak, many referring clinicians will order imaging.
Side-Effect Management
CDC Clarifies Position on Use of Opioids in Patients With Cancer
CDC guidelines published in 2016 on prescribing opioids for chronic pain prompted questions regarding their application to patients with cancer and sickle cell anemia.
Toolbox Enables Quick Response to Anticancer Therapy-Induced Hypersensitivity Reactions
In this study, investigators analyzed internal hypersensitivity data from 2017, then developed a multidisciplinary subgroup within the Anticancer Therapy Council to improve response practices.
Addressing the Need for Palliative Care Integration Into Phase 1 Clinical Trials
Researchers argue that palliative care integration into treatment regimens contribute to improving the quality of life for patients in phase 1 clinical trials.
Cannabis Products Used Differ for Cancer, Noncancer Patients
Cancer patients more likely to use sublingual tincture form; noncancer patients often use vaporization form
Liver Function Assessment
Child Pugh Score liver function assessment chart for cirrhosis patients.
Anticoagulant Dosing Conversions
Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.
Opioid Equianalgesic Doses
Opioid equianalgesic dosing chart used for interchanging between drug, route of administration, or both.
Chemobrain: Experts Weigh in on Very Real — and Growing — Problem
Major advances in cancer treatment in recent decades have allowed patient survival rates to increase.
Additional Method of Administration Approved for Cinvanti in Chemotherapy-Induced Nausea and Vomiting
Heron Therapeutics announced that the Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Cinvanti (aprepitant) to expand administration to include a 2-minute intravenous (IV) injection, in addition to the already approved 30-minute IV infusion.
Next post in Side Effect Management
